A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Duke Cancer Institute, Durham

Northside Hospital, Atlanta

Florida Cancer Specialists, Sarasota

Vanderbilt University Medical Center, Nashville

Vanderbilt University, Nashville

Gabrail Cancer Center, Canton

START Midwest, Grand Rapids

Washington University School of Medicine, St Louis

University of Oklahoma Medicine Stephenson Cancer Center, Oklahoma City

NEXT Oncology, San Antonio

UT Health San Antonio - Mays Cancer Center, San Antonio

Sarah Cannon Research Institute at HealthONE, Denver

START Mountain Region, West Valley City

Honor Health Research Institute, Scottsdale

University of Arizona Cancer Center, Tucson

City of Hope Medical Center, Duarte

UC Davis - Comprehensive Cancer Center, Sacramento

Dana Farber Cancer Institute, Boston